CCND3P2

Across TCGA pan-cancer cohorts, CCND3P2 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated CCND3P2 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher CCND3P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CCND3P2 expression acts as an unfavorable survival marker.

THCA, KIRC, and BLCA are the cancer types where CCND3P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.902	0.991	<.001	132	view →
KIRC	DFS	Tertile	II,III,IV	0.229	0.662	.016	36	view →
BLCA	DFS	Tertile	All	0.213	0.527	.003	36	view →
UCS	DFS	Tertile	All	0.130	0.462	.009	36	view →
LUSC	OS	Tertile	All	0.242	0.765	<.001	33	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

CCND3P2–THCA (OS)

Open the THCA breakdown →